1. Home
  2. CFBK vs IVVD Comparison

CFBK vs IVVD Comparison

Compare CFBK & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFBK
  • IVVD
  • Stock Information
  • Founded
  • CFBK 1892
  • IVVD 2020
  • Country
  • CFBK United States
  • IVVD United States
  • Employees
  • CFBK N/A
  • IVVD N/A
  • Industry
  • CFBK Major Banks
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • CFBK Finance
  • IVVD Health Care
  • Exchange
  • CFBK Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • CFBK 127.9M
  • IVVD 123.8M
  • IPO Year
  • CFBK 1998
  • IVVD 2021
  • Fundamental
  • Price
  • CFBK $21.87
  • IVVD $0.61
  • Analyst Decision
  • CFBK
  • IVVD Strong Buy
  • Analyst Count
  • CFBK 0
  • IVVD 3
  • Target Price
  • CFBK N/A
  • IVVD $7.52
  • AVG Volume (30 Days)
  • CFBK 13.4K
  • IVVD 1.7M
  • Earning Date
  • CFBK 05-06-2025
  • IVVD 05-08-2025
  • Dividend Yield
  • CFBK 1.35%
  • IVVD N/A
  • EPS Growth
  • CFBK N/A
  • IVVD N/A
  • EPS
  • CFBK 2.06
  • IVVD N/A
  • Revenue
  • CFBK $45,082,000.00
  • IVVD $25,384,000.00
  • Revenue This Year
  • CFBK N/A
  • IVVD $606.63
  • Revenue Next Year
  • CFBK N/A
  • IVVD $83.30
  • P/E Ratio
  • CFBK $10.07
  • IVVD N/A
  • Revenue Growth
  • CFBK N/A
  • IVVD N/A
  • 52 Week Low
  • CFBK $16.92
  • IVVD $0.36
  • 52 Week High
  • CFBK $31.17
  • IVVD $2.74
  • Technical
  • Relative Strength Index (RSI)
  • CFBK 55.08
  • IVVD 43.08
  • Support Level
  • CFBK $20.00
  • IVVD $0.46
  • Resistance Level
  • CFBK $21.03
  • IVVD $0.56
  • Average True Range (ATR)
  • CFBK 0.74
  • IVVD 0.06
  • MACD
  • CFBK 0.18
  • IVVD 0.02
  • Stochastic Oscillator
  • CFBK 93.47
  • IVVD 73.23

About CFBK CF Bankshares Inc.

CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: